The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Alstrom Syndrome: Genetics and Clinical Overview
Open accessAbstract
Alström syndrome is a rare autosomal recessive genetic disorder characterized by cone-rod dystrophy, hearing loss, childhood truncal obesity, insulin resistance and hyperinsulinemia, type 2 diabetes, hypertriglyceridemia, short stature in adulthood, cardiomyopathy, and progressive pulmonary, hepatic, and renal dysfunction. Symptoms first appear in infancy and progressive development of multi-organ pathology leads to a reduced life expectancy. Variability in age of onset and severity of clinical symptoms, even within families, is likely due to genetic background.Alström syndrome is caused by mutations in ALMS1, a large gene comprised of 23 exons and coding for a protein of 4,169 amino acids. In general, ALMS1 gene defects include insertions, deletions, and nonsense mutations leading to protein truncations and found primarily in exons 8, 10 and 16. Multiple alternate splice forms exist. ALMS1 protein is found in centrosomes, basal bodies, and cytosol of all tissues affected by the disease. The identification of ALMS1 as a ciliary protein explains the range of observed phenotypes and their similarity to those of other ciliopathies such as Bardet-Biedl syndrome.Studies involving murine and cellular models of Alström syndrome have provided insight into the pathogenic mechanisms underlying obesity and type 2 diabetes, and other clinical problems. Ultimately, research into the pathogenesis of Alström syndrome should lead to better management and treatments for individuals, and have potentially important ramifications for other rare ciliopathies, as well as more common causes of obesity and diabetes, and other conditions common in the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Proteomic characterization of the human centrosome by protein correlation profiling
Andersen, J. S., Wilkinson, C. J., Mayor, T., Mortensen, P., Nigg, E. A., & Mann, M. (2003) · Nature · doi:10.1038/nature02166 · Cited by 1,319
Centrioles, Centrosomes, and Cilia in Health and Disease
Nigg, E. A., & Raff, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.10.036 · Cited by 902
New loci associated with kidney function and chronic kidney disease
Köttgen, A., Pattaro, C., Böger, C. A., Fuchsberger, C., Olden, M., Glazer, N. L., Parsa, A., Gao, X., Yang, Q., Smith, A. V., et al. (2010) · Nature Genetics · doi:10.1038/ng.568 · Cited by 804
Carrier testing for severe childhood recessive diseases by next-generation sequencing
Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., Langley, R. J., Zhang, L., Lee, C. C., Schilkey, F. D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001756 · Cited by 706 · cited 1×
“new efficient and cost effective means for identifying ALMS1 mutations and will be useful for carrier testing [12].”
BackgroundMutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome
Collin, G. B., Marshall, J. D., Ikeda, A., So, W. V., Russell-Eggitt, I., Maffei, P., Beck, S., Boerkoel, C. F., Sicolo, N., Martin, M., et al. (2002) · Nature Genetics · doi:10.1038/ng867 · Cited by 404
Self-citationNew Alström Syndrome Phenotypes Based on the Evaluation of 182 Cases
Marshall, J. D., Bronson, R. T., Collin, G. B., Nordstrom, A. D., Maffei, P., Paisey, R. B., Carey, C., MacDermott, S., Russell-Eggitt, I., Shea, S. E., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.6.675 · Cited by 313
Self-citationHearn, T., Renforth, G. L., Spalluto, C., Hanley, N. A., Piper, K., Brickwood, S., White, C., Connolly, V., Taylor, J. F. N., Russell-Eggitt, I., et al. (2002) · Nature Genetics · doi:10.1038/ng874 · Cited by 309
Wallingford, J. B., & Mitchell, B. (2011) · Genes & Development · doi:10.1101/gad.2008011 · Cited by 307
Genetic loci influencing kidney function and chronic kidney disease
Chambers, J. C., Zhang, W., Lord, G. M., van der Harst, P., Lawlor, D. A., Sehmi, J. S., Gale, D. P., Wass, M. N., Ahmadi, K. R., Bakker, S. J. L., et al. (2010) · Nature Genetics · doi:10.1038/ng.566 · Cited by 273
Cited by
Motile and non-motile cilia in human pathology: From function to phenotypes
Mitchison, H. M., & Valente, E. M. (2017) · The Journal of Pathology · doi:10.1002/path.4843 · Cited by 448
Triple Vectors Expand AAV Transfer Capacity in the Retina
Maddalena, A., Tornabene, P., Tiberi, P., Minopoli, R., Manfredi, A., Mutarelli, M., Rossi, S., Simonelli, F., Naggert, J. K., Cacchiarelli, D., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.019 · Cited by 128
Quantitative comparison of primary cilia marker expression and length in the mouse brain
Sipos, É., Komoly, S., & Ács, P. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1036-z · Cited by 61
Marrone, L., Marchi, P. M., & Azzouz, M. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2012148 · Cited by 56
“trafficking, and adipocyte differentiation [107].”
Mouse models of human ocular disease for translational research
Krebs, M. P., Collin, G. B., Hicks, W. L., Yu, M., Charette, J. R., Shi, L. Y., Wang, J., Naggert, J. K., Peachey, N. S., & Nishina, P. M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183837 · Cited by 51
Self-citation
Metadata
- Authors
- D. Marshall, J., Maffei, P., B. Collin, G., & K. Naggert, J.
- Venue
- Current Genomics
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-05-01
- Volume
- 12
- Issue
- 3
- Pages
- 225-235
- ISSN
- 1389-2029 (ISSN-L)
- OpenAlex
- W1979818630
- Cited by
- 263
- References
- 52
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alstrom Syndrome: Genetics and Clinical Overview. https://app.cochat.ai/papers/10.2174/138920211795677912
- The paper
- D. Marshall, J., Maffei, P., B. Collin, G., & K. Naggert, J. (2011). Alstrom Syndrome: Genetics and Clinical Overview. Current Genomics. https://doi.org/10.2174/138920211795677912
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.